The CD34+ cell: Biological aspects;Le cellule CD34+: Aspetti biologici

Tumori

Volumn 82, Issue 2 SUPPL., 1996, Pages

  Benedetti, Fabio ^a,b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

CD34 antigen; peripheral blood stem cells; positive and negative selection

Indexed keywords

CD34 ANTIGEN;

CELL ISOLATION; CONFERENCE PAPER; HUMAN; PERIPHERAL BLOOD STEM CELL;

ANIMALS; ANTIGENS, CD34; CELL SEPARATION; FLOW CYTOMETRY; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0030038287     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (73)

1. Andrews R.G., Bryanr E.M., Bartelmez S.H., Miurhead D.Y., Knitter G.H., Bensinger W.I., Strong D.M., Bernstein I.D. CD34 marrow cells, devoid of T and B lymphocytes, reconstitute stable lymphopoiesis and myelopoiesis in lethally irradiated allogenic baboons. Blood, 80:1693-1699, 1992.
2. Andrews R.G., Singer J.W., Bernstein ID. Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J. Exp. Med., 169:1721-1731, 1989.
3. Aversa F., Tabilio A., Terenzi A., Velardi A., Falzeti F., Giannoni C., Iacucci R., Zei T., Martelli M.P., Gambelunghe C., Rossetti M., Caputo P., Latini P., Aristei C., Raymondi C., Reisner Y., Martelli M.: Successfull engraftment of T-cell depleted haploidentical "three-loci" incompatible transplant in leukemia patients by adding of recombinant human colony stimulating factor mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood, 84: 3948-3955, 1994.
4. Berenson R.J., Andrews R.G., Bensinger W.I., Kalamasz D.F., Knitter G., Buckner C.D., Bernstein I.D.: CD34+ marrow cells engraft lethally irradiated baboons. J. Clin. Invest., 81: 951-959, 1988.
5. Berenson R.J., Bensinger W.I., Hill R.S., Andrews R.G., Garcia-Lopez J., Kalamasz D.F., Still B.J., Spitzer G., Buckner C.D., Bernstein I.D., Thomas E.D.: Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood, 77: 1717-1722, 1991.
6. Borowitz M.J., Shuster J.J., Civin C.I., Andrew J.C., Look A.T., Behm F.G., Land V.J., Pullen D.J., Crist W.M.: Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: a pediatric oncology group study. J. Clin. Oncol., 8: 1389-1396, 1990.
7. Bregni M., Magni M., Siena S., Di Nicola M., Bonadonna G., Gianni A.M.: Human peripheral blood hematopoietic progenitors are optimal targets of retroviral mediated gene transfer. Blood, 80: 1218-1222, 1992.
8. Brenner M.K., Rill D.R., Moen R.C., Krance R.A., Mirro J., Anderson W.F., Ihle J.N.: Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet, i: 85-87, 1993.
9. Brugger W., Bross K.J., Glatt M., Weber F., Mertelsmann R., Kanz L.: Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood, 83: 636-642, 1994.
10. Brugger W., Bross K., Frisch J., Dern P., Weber B., Mertelsmann R., Kanz L.: Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide and cisplatin. Blood, 79: 1193-1200, 1992.
11. Civin C.I., Strauss L.C., Brovall C., Fackler M.J., Schwartz J.F., Shaper J.H.: Antigenic analysis of hematopoiesis III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J. Immunol., 133: 157-165, 1984.
12. Civin C.I., Strauss L.C., Fackler M.J., Trismann T.M., Wiley J.M., Loken R.L.: Positive stem cell selection. Basic science. In: Bone Marrow Purging and Processing, 387-402, S. Gross, A. Gee, D.A. Worthington White, Eds., Wiley-Liss, New York, 1990.
13. Corradini P., Voena C., Omedé P., Astolfi M., Boccadoro M., Dalla-Favera R., Pileri A.: Detection of circulating tumor cells in multiple myeloma by a PCR-based method. Leukemia, 7: 1879-1888, 1993.
14. Cot R., Rosen P.P., Old L.J., Osborne M.P.: Detection of bone, marrow micrometastases in patients with early-stage. Breast Cancer Diagn. Oncol., 1: 37-45, 1991.
15. Demirez T., Buckner C.D., Bensinger W.J.: Optimization of peripheral blood stem cell mobilization. Stem Cells, 14: 106-116, 1996.
16. Douay L., Gorin N.C., Lemarie E.: Recovery of CFU-GM in cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment. Exp. Hematol., 14: 358-367, 1986.
17. Dreyfus R., Melle J., Quarre M.C., Piller C.: Contamination of peripheral blood by monoclonal B cells following treatment of multiple myeloma by high-dose chemotherapy. Br. J. Haematol., 85: 411-420, 1993.
18. Duhrse U., Villeval J.L., Boyd J., Kannourakis G., Morstyn G., Metcalf D.: Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood, 72: 2074-2081, 1988.
19. Fina L., Molgaard H.V., Robertson D., Bradley N.J., Monaghan P., Delia D., Sutherland D.R., Baker M.A., Greeves M.F.: Expression of the CD34 gene in vascular endothelial cells. Blood, 75: 2417-2426, 1990.
20. Gee A.: Purging of peripheral blood stem cell graft. Stem Cell, 13 (suppl): 52-62, 1995.
21. Gianni A.M., Siena S., Bregni M., Tarella C., Stern A.G., Pileri A., Bonadonna G.: Granulocyte-macrophage colony-stimulating factor to harvest circulating haematopoietic stem cells for autotransplantation. Lancet, ii: 580-585, 1989.
22. Goodman J.W., Hodgson G.S.: Evidence for stem cells in the peripheral blood in mice. Blood, 702-714, 1962.
23. Gribben J.G., Neuberg D., Barber M., Moore J., Pesek K., Freedman A.S., Nadler L.M.: Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood, 83: 3800-3811, 1994.
24. Heimfeld S., Berenson R.J.: Clinical transplantation of CD34+ hematopoietic progenitor cells: positive selection using a closed, automated avidin-biotinimmunoabsorption system. In: Hematopoietic stem cells. The Mulhouse Manual, Wunder E., Sovalat H., Hénon P.R., Serke S., Eds, 231-239, Alpha Med, Dayton, 1994.
25. Henscheler R., Brugger W., Luft T., Frey T., Mertelsmann R., Kanz L.: Maintenance of transplantation potential in ex-vivo expanded CD34+ selected human peripheral blood progenitor cells. Blood, 84: 2898-2906, 1994.
26. Ho A.D., Xiqiang I.I., Thomas A.L., Yu M., Law P., Wong-Staal F.: Stem cells as vehicles for gene therapy: novel strategy for HIV infection. Stem Cells, 13 (suppl 3): 100-105, 1995.
27. Huang S., Terstappen L.W.M.M.: Lymphoid and myeloid differentiation of single human CD34+, HLA-DR-, CD38- hematopoietic stem cells. Blood, 83: 1515-1526, 1994.
28. Imrie K., Dicke K.A., Keating A.: Autologous bone marrow transplantation for acute myeloid leukemia. Stem Cells, 14: 69-78, 1996.
29. Jansen W.E.: Peripheral blood and bone marrow hematopoietic stem cells: are they the same? Semin. Oncol., 20: 19-27, 1993.
30. Keij J.F., Groenenwegen A.C., Visser J.W.M.: High speed photo-damage cell sorting: an evaluation of the zapped prototype. In: Methods in cell biology, Vol. 42, Darzynkiewicz Z., Robinson J.P., Crissman H.A., Eds, 371-378, Academic Press, New York, 1994.
31. Kessinger A., Armitage J.O.: The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood, 77: 211-213, 1991.
32. Kessinger A.: Do autologous peripheral blood cell transplantation provide more than hematopoietic recovery? Stem Cells, 13: 351-354, 1995.
33. Korbling M.: Blood stem cell transplantation and gene therapy of cancer. Stem Cells, 13(suppl 3): 106-113, 1995.
34. Kruger H., Stockschlader M., Zander A.R.: Detection of epithelial specific RNA in blood and bone marrow with a RT-based polymerase chain reaction. Proc. Am. Assoc. Clin. Oncol. 74: 68, 1994 (Abstract).
35. Lanza F., Castoldi G.L.: Large scale enrichment of CD34+ cells by Percoll density gradients: a CML-based study design. In: Hematopoietic stem cells, Wunder E., Serke S., Solovat H., Henon P., Eds., 255-270, Alpha Med. Press., Dayton, 1993.
36. Lanza F., Moretti S., Papa S., Malavasi F., Castoldi G.: Report on the fifth international workshop on human leukocyte differentiation antigens, Boston, November 3-7, 1993. Haematologica, 79: 374-386, 1994.
37. Lebkowsky J.S., Schain L.R., Okrongly D., Levinsky R., Harvey M.J., Okarma T.B.: Rapid isolation of human CD34 hematopoietic stem cells-purging of human tumor cells. Transplantation, 53: 1011-1019.
38. Mansi J.L., Berger U., McDonnel T., Pople A., Rayter Z., Gazet J.C., Coombes R.C.: The fate of bone marrow micrometastases in patients with primary breast cancer. J. Clin. Oncol., 7: 445-451, 1989.
39. Matsunaga T., Sakamaki S., Ohi S., Hirayama Y., Niitsu Y.: Recombinant human granulocyte colony-stimulating factor can monilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogenic transplantation. Bone Marrow Transpl., 11: 103-198, 1993.
40. Menichella G., Pierelli L., Foddai M.L., Paoloni A., Vittori M., Serafini R., Benedetti Panici P., Scambia G., Baiocchi G., Greggi S., Laurelli G., Salerno G., Mancuso S., Mango G., Bizzi B.: Autologous blood stem cell harvesting and transplantation in patients with advanced ovarian cancer. Br. J. Haematol., 79: 444-450, 1991.
41. Miller J.S., Verfaillie C., McGlave P.: The generation of human natural killer cells from CD34+/DR- primitive progenitors in long term bone marrow culture. Blood, 80: 2182-2187, 1992.
42. Miltenyi S., Guth S., Radbruch A.: Isolation of CD34+ hematopoietic progenitor cells by high gradient magnetic cell sorting (MACS). In: Hematopoietic stem cells, The Mulhouse Manual, Wunder E., Sovalat H., Hénon P.R., Serke S., Eds, 211-213, Alpha Med., Dayton, 1994.
43. Molino A., Colombatti M., Bonetti F., Zardini M., Pasini F., Perini A., Pelosi G., Tridente G., Veneri D., Cetto G.L.: A comparative analysis of three different techniques for the detection of breast cancer cells in bone marrow. Cancer, 67: 1033-1038, 1991.
44. Moore M.A.S.: Clinical implications of positive and negative hematopoietic stem cell regulators. Blood, 78: 1-19, 1991.
45. Myint H., Lucie N.P.: The prognostic significance of the CD34 antigen in acute mieloid leukaemia. Leuk. Lymphoma, 7: 425-429, 1992.
46. Ogawa M.: Differentiation and proliferation of hematopoietic stem cells. Blood, 81: 2844-2853, 1993.
47. Osborne M.P., Wong G.Y., Asina S., Old L.J., Cot R., Rosen P.P.: Sensitivity of immunocytochemical detection of breast cancer cells in human bone marrow. Cancer Res., 51: 2706-2713, 1991.
48. Peters W., Rosner G., Ross M., Vredenburgh J., Meisenberg B., Gilbert C., Kurtzberg J.: Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow transplantation after high-dose chemotherapy. Blood, 81: 1709-1719, 1993.
49. Pettengell R., Morgenstern G.R., Woll P.J., Chang J., Rowlands M., Young R., Radford J.A., Scarffe J.H., Testa N.G., Crowther D.: Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood, 82: 3770-3777, 1993.
50. Pettengell R., Testa N.G., Swindell R., Crowther D., Dexter T.M.: Transplantation potential of hematopoietic cell released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma. Blood, 82: 2239-48, 1993.
51. Pierelli L.: Haemopoietic reconstitution after autologous blood stem cell transplantation in patients with malignacies: a multicentre retrospective study. Br. J. Haematol., 86: 70-75, 1994.
52. Pui C.H., Hancock M.L., Head D.R., Rivera G.K., Look A.T., Sandlund J.T., Behem F.G.: Clinical significance of CD34 expression in childhood acute lymphoblastic leukemia. Blood, 82: 889-894, 1993.
53. Ravagnani F., Siena S., Bregni M., Sciorelli G., Gianni A.M., Pellegris G.: Large scale collection of circulating haematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human GM-CSF. Eur. J. Cancer, 26: 562-564, 1990.
54. Reiffers J. Peripheral blood stem cell transplantation in acute myeloid leukemia: the experience of the Bordeaux group. Stem Cells, 13 (suppl 3), 19-22, 1996.
55. Richman C.M., Weiner R.S., Yankee R.A.: Increase in circulating stem cells following chemotherapy in man. Blood, 47: 1031-1034, 1976.
56. Ross A., Cooper B.W., Lazarus H.M., Mackay W., Moss T.J., Ciobanu N., Tallman M.S., Kennedy M.J., Davidson N.E., Sweet D., Winter Akard C.L., Jansen J., Copelan E., Meagher R.C., Herzig R.H., Klumpp T.R., Kahn D.J., Warner N.E.: Detection of viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood, 82: 2605-2610, 1994.
57. Schlimok G., Funke I., Bock B., Schweiberer B., Witte J., Riethmuller G.: Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization and prognostic significance. J. Clin. Oncol., 8: 831-834, 1990.
58. Serke S., Sauberlich S., Huhn D.: Multiparameter flow cytometrical quantitation of circulating CD34+ cells: correlation to the quantitation of circulating haemopoietic progenitor cells by in vitro colony assay. Br. J. Haematol., 77: 453-459, 1991.
59. Shpall E.J., Jones R.B., Bearman S.I., Franklin W.A., Archer P.G., Curiel T., Bitter M., Claman H.N., Stemmer S.M., Purdy M., Mayers S.E., Hami L., Taffs S., Heimfeld S., Hallagan J., Berenson R.J.: Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral blood progenitors and growth factors on engraftment. J. Clin. Oncol., 12, 28-36, 1994.
60. Siena S., Bregni M., Bonsi L., Sklenar I., Bagnara G.P., Bonadonna G.: Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors. Exp. Hematol., 21: 1583-1590, 1993.
61. Siena S., Bregni M., Di Nicola M., Ravagnani F., Peccatori F., Gandola L., Lombardi F., Tarella C., Bonadonna G., Gianni A.M.: Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitors. Ann Oncol., 5: 935-941, 1994.
62. Siena S., Bregni M., Brando B., Belli N., Ravagnani F., Gandola L., Stern A.C., Lansdorp P.M., Bonadonna G., Gianni A.M.: Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood, 77: 400-409, 1992.
63. Siena S., Bregni M., Brando B., Ravagnani F., Bonadonna G., Gianni A.M.: Circulation of CD34-positive hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide treated patients: enhancement by intravenous recombinant human GM-CSF. Blood, 74: 1905-1914, 1989.
64. Silvestri F., Banavali S., Baccarani M., Preisler H.D.: Progenitor cell associated antigen CD34: biology and clinical applications. Haematologica, 77: 265-272, 1992.
65. Smeland E.B., Funderud S., Kvalheim G., Gaudernack G., Rasmussen A.M., Rusten L., Wang M.Y., Tindle R.W., Blomhoff H.K., Egeland T.: Isolation and characterisation of human hematopoietic progenitor cells: an effective method positive selection of CD34+ cells. Leukemia, 6: 845-852, 1992.
66. Socinski M.A., Elias A., Schnipper L., Cannistra S.A., Antman K.H., Griffin J.D.: Granulocyte-macrophage colony-stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet, i: 1194-1198, 1988.
67. Stahel A., Mabry M., Skarin A.T., Speak J., Bernal S.D.: Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody. J. Clin. Oncol., 3: 455-459, 1985.
68. Sutherland H.J., Eaves C.J., Lansdorp P.M., Phillips G.L., Hogge D.E.: Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor and their use in autotransplants. Blood, 83: 3808-3816, 1994.
69. Terstappen L.W.M.M., Huang S., Safford M., Lansdorp P., Loken M.R.: Sequential generation of hematopoietic colonies derived from single non-lineage committed CD34+/CD38-progenitor cells. Blood, 77: 1218-1227, 1991.
70. Uchida N., Aguila H.L., Fleming W.H., Jerabek L., Weissman I.L.: Rapid and sustained hematopoietic recovery in lethally irradiated mice transplanted with purified Thy-1.loLin-Sca-1+hematopoietic stem cells. Blood, 83: 3758-3779, 1994.
71. Verfaillie C., Miller W.J., Boylan K., McGlave P.B.: Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression. Blood, 79: 1003-1010, 1992.
72. Weaver C.H., Buckner C.D., Longin K., Appelbaum F.R., Rowley S., Lilleby K., Miser J., Storb R., Hansen J.A., Bensinger W.: Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood, 82: 1981-1984, 1993.
73. Wunder E., Herbein G., Sovalat H., Kirn A.: Separation of hematopoietic cells of different maturity in mononuclear cells susets generated by elutriation. In: Hematopoietic stem cells, The Mulhouse Manual, Wunder E., Sovalat H., Hénon P.R., Serke S., Eds, 271-279, Alpha Med., Dayton, 1994.